Cat.#: ACPP-1220
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1462 | Human CD34 Protein (AC1462) | 5 µg | inquiry |
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg | inquiry |
| ACPP-1376 | Mouse S100A5 Protein (AC1376) | 5 µg | inquiry |
| ACPP-1254 | Luteinizing Hormone Blocking Peptide (AC1254) | 250 µg | inquiry |
| ACPP-1831 | Human STOM Protein (AC1831) | 5 µg | inquiry |
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
| ACPP-1386 | Human HMGN1 Protein (AC1386) | 2 µg | inquiry |
| ACPP-1401 | Rat Midkine Protein (AC1401) | 5 µg | inquiry |
| ACPP-1074 | Myocilin Blocking Peptide (AC1074) | 250 µg | inquiry |
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.